Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment.
about
Controversies in the management of primary sclerosing cholangitisRole of endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures: What's new?Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialistsPrimary sclerosing cholangitis: diagnosis and treatmentPrimary sclerosing cholangitis: diagnostic and therapeutic problems.S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.Treatment of autoimmune liver disease: current and future therapeutic options.Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis.A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis.Indications for intestinal transplantation: recognizing the scope and limits of total parenteral nutrition.Endoscopic Treatment of Biliary Stenosis in Patients with Alveolar Echinococcosis--Report of 7 Consecutive Patients with Serial ERC ApproachCholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experienceMicrobiological Assessment of Bile and Corresponding Antibiotic Treatment: A Strobe-Compliant Observational Study of 1401 Endoscopic Retrograde Cholangiographies.Endoscopic retrograde cholangiopancreatography for non-gastroenterologists: what you need to know.Primary sclerosing cholangitis: is any treatment worthwhile?Non-IBD immunological diseases are a risk factor for reduced survival in PSC.Role of endoscopy in primary sclerosing cholangitis.Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist.A common genetic variant of fucosyltransferase 2 correlates with serum carcinoembryonic antigen levels and affects cancer screening in patients with primary sclerosing cholangitis.Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?CD14 is associated with biliary stricture formation.What is the current role of endoscopy in primary sclerosing cholangitis?Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.The endoscopist and malignant and non-malignant biliary obstruction.Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.
P2860
Q26765804-55017EC7-4E64-4D14-B552-9F41BD1195D0Q26766651-306C3A33-640F-449B-9824-20AA0FDD549AQ26796355-D0C11B88-E339-49FE-822F-A2B5ABFBCF92Q26829216-AD681992-505F-416B-A283-498BD7B4FE34Q34079772-B83A6B2C-157E-4A56-9B0D-4E457DA2B51AQ34130667-ADA4F3DB-03CB-4F6E-8665-7EC676932592Q34342199-9F08F829-FF4F-40FD-83E4-42BF72CF9CBAQ34403316-9A816C14-F788-4ADE-899D-0937469AF117Q34626025-4FA4A58C-5809-41F9-9CD0-F38356B6BD3AQ34889470-E3FFE63A-D42F-459E-9A50-1B5E47D9C926Q35934247-BEC1FECD-3234-4875-B7D3-14A7D4CA50A8Q36644248-93580C80-EAED-444B-A9D9-E4C26290C004Q37206914-6B1157C9-510A-4E77-8FBC-11194C7FC552Q37876078-8F529AFE-7F69-4D86-9B60-666F16B8A072Q37962395-45A98285-59E2-4368-B378-CD35C126CD56Q38060237-BA3267F7-847E-4DE4-8E52-D6B83ED0915DQ38164560-D03A35A8-D93B-4DF5-8FE6-036A8674CBA6Q38443665-71FA785D-84A9-4779-A0D9-8E5D5983B549Q38623360-06A3A7B7-A7C4-49B0-8478-7BDB170698F7Q38657903-CAA3E9E0-FDB0-4A9F-B032-0D3577784413Q38896152-918353EA-07F1-481C-8496-A836CC736F52Q42428693-3FFACEF3-9A85-4420-BBFA-07BDE0455151Q45375843-DBD39256-84E5-4B8D-9BF6-349B30323103Q49985905-95BC9262-9A30-4BD1-A804-5E9D4CFEFA36Q52670887-2258F9C4-D32A-4D33-BDA3-68046F7CA5FA
P2860
Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Endoscopic dilation of dominan ...... ome after long-term treatment.
@en
Endoscopic dilation of dominan ...... ome after long-term treatment.
@nl
type
label
Endoscopic dilation of dominan ...... ome after long-term treatment.
@en
Endoscopic dilation of dominan ...... ome after long-term treatment.
@nl
prefLabel
Endoscopic dilation of dominan ...... ome after long-term treatment.
@en
Endoscopic dilation of dominan ...... ome after long-term treatment.
@nl
P2093
P1476
Endoscopic dilation of dominan ...... ome after long-term treatment.
@en
P2093
Adolf Stiehl
Daniel N Gotthardt
Gerda Rudolph
Hasan Kulaksiz
Petra Klöters-Plachky
P304
P356
10.1016/J.GIE.2009.10.041
P407
P577
2010-03-01T00:00:00Z